SEC Info - Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics Holdings, Inc. – ‘15-12B’ on 9/25/19

Pernix Therapeutics Holdings, Inc. – ‘15-12B’ on 9/25/19

On: Wednesday, 9/25/19, at 2:40pm ET · Effective: 9/25/19 · Accession #: 1136261-19-235 · File #: 1-14494

Certification of Termination of Registration of a Class of Securities — Form 15 — Sect. 12(b) – SEA’34
Filing Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein

On: Wednesday, 9/25/19, at 2:40pm ET · Effective: 9/25/19 · Accession #: 1136261-19-235 · File #: 1-14494

Certification of Termination of Registration of a Class of Securities — Form 15 — Sect. 12(b) – SEA’34Filing Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein

Certification of Termination of Registration of a Class of Securities — Form 15 — Sect. 12(b) – SEA’34
Filing Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-14494

PERNIX THERAPEUTICS HOLDINGS, INC.
(Exact name of registrant as specified in its charter)

10 North Park Place, Suite 201
Morristown, NJ 07960
(800) 793-2145
(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

Common Stock, par value $0.01 per share
(Title of each class of securities covered by this Form)

None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:


Rule 12g-4(a)(1)		☒
Rule 12g-4(a)(2)		☐
Rule 12h-3(b)(1)(i)		☒
Rule 12h-3(b)(1)(ii)		☐
Rule 15d-6		☐
Rule 15d-22(b)		☐

Approximate number of holders of record as of the certification or notice date: 0

Pursuant to the requirements of the Securities Exchange Act of 1934, Pernix Therapeutics Holdings, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

This ‘15-12B’ Filing	Date	Other Filings

Filed on / Effective on:	9/25/19	None on these Dates
		List all Filings

Date: September 25, 2019

PERNIX THERAPEUTICS HOLDINGS, INC.

/s/ Garineh Dovletian

Garineh Dovletian

Wind Down Officer